在石墨烯/花色素复合海绵上精确地表面固定,用于快速止血的不受控制的出血
Fanglin Du1, Yuanhang Wang1, Wengjing A1
1State Key Laboratory of Organic-Inorganic Composites, Beijing Laboratory of Biomedical Materials, Beijing University of Chemical Technology, Beijing 100029, China.
Colloids and surfaces. B, Biointerfaces
|May 2, 2025
概括
一种新的固定石墨烯/奇托桑海绵 (GCCS-TRAP) 为创伤出血提供快速和安全的静血. 这种先进的材料显著减少血液流失并增强凝血,对紧急医疗非常有前途.
科学领域:
- 生物材料科学 生物材料科学
- 材料化学 材料化学
- 生物医学工程 生物医学工程
背景情况:
- 创伤引起的出血需要有效的止血剂.
- 当前材料在平衡有效性,安全性和速度方面面临着挑战.
- 先进的复合材料为改善静血性能提供了潜力.
研究的目的:
- 开发一种新型的固定型石墨烯/酸盐复合海绵 (GCCS-TRAP),用于增强血液静止.
- 评估GCCS-TRAP的静血疗效,机械性能和生物相容性.
- 调查作用机制,包括血小板激活和凝血级联参与.
主要方法:
- 在石墨烯/奇托桑海绵上使用烯光点击化学来固定.
- 评估液体吸收,机械强度和体外凝固特性.
- 在大鼠大腿动脉出血模型中的体内评估,将GCCS-TRAP与商业血静止剂进行比较.
- 生物相容性测试,包括血液溶解和细胞毒性测试.
主要成果:
- GCCS-TRAP显示出高液体吸收率 (30倍重量) 和快速吸收率 (0.27秒).
- 海绵表现出显著的机械强度 (96.3 kPa) 和卓越的体外凝血 (7.1%的血液凝血指数).
- 在体内,GCCS-TRAP在81.3秒内实现了静血,与对照组相比,减少了62%的血液损失.
- 观察到极好的生物相容性,血解和细胞毒性最小.
结论:
- 通过光点击化学来固定,产生一种高效的静血海绵.
- GCCS-TRAP在吸收,机械强度和体内血液静止方面表现出卓越的表现.
- 这种材料代表了一个有前途的下一代静血剂,具有最佳的疗效和安全性.
相关概念视频
Introduction to Hemostasis
6.6K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
6.6K
Formation of the Platelet Plug
5.3K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
5.3K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
652
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
652
Extrinsic and Intrinsic Pathways of Hemostasis
6.5K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
6.5K
Clot Retraction and Fibrinolysis
4.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
4.9K
Coagulation
5.6K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
5.6K


